Tag: GLP1
ImmunoPrecise Unveils AI-Designed GLP-1 Therapy Alternative with Transdermal Delivery Potential
ImmunoPrecise Antibodies (NASDAQ: IPA) has developed a new class of GLP-1 therapies using artificial intelligence…
Fed Beige Book, Nvidia’s Blackwell, GLP-1 drugs: Market Domination
It’s 3 p.m., so you know what that means — time for Market Domination with Julie Hyman and Josh Lipton,…